The present invention provides methods for treating a PCSK9-mediated disease or a PCSK9-mediated condition. Specifically, the invention relates to methods comprising the administration of a proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody or antigen binding protein, in the absence of a statin, to a subject in need thereof.
申请公布号
WO2015073494(A8)
申请公布日期
2016.05.19
申请号
WO2014US65149
申请日期
2014.11.12
申请人
SANOFI BIOTECHNOLOGY;REGENERON PHARMACEUTICALS, INC.
发明人
BACCARA-DINET, MARIE;BESSAC, LAURENCE;HANOTIN, CORINNE;PORDY, ROBERT, C.;SASIELA, WILLIAM, J.;REY, JACQUES